Julie Vose, MD Professor Internal Medicine Division of Oncology & Hematology University of Nebraska Medical Center, discusses Does Polatuzumab Improve Outcomes In DLBCL Patients. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
Advertisement